Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria

To pave the way for healthy aging in early treated phenylketonuria (ETPKU) patients, a better understanding of the neurological course in this population is needed, requiring easy accessible biomarkers to monitor neurological disease progression in large cohorts. The objective of this pilot study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotz-Havla, Amelie S., Katzdobler, Sabrina, Nuscher, Brigitte, Weiß, Katharina, Levin, Johannes, Havla, Joachim, Maier, Esther M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559705/
https://www.ncbi.nlm.nih.gov/pubmed/36247773
http://dx.doi.org/10.3389/fneur.2022.1011470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559705/
https://www.ncbi.nlm.nih.gov/pubmed/36247773
http://dx.doi.org/10.3389/fneur.2022.1011470

Ejemplares similares